EnGro Corporation (S44) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
28 Oct, 2026Executive summary
H1 revenue rose 70.3% YoY to $177.9m and net profit increased to $35.2m from $8.7m; results included a $22.8m unrealised, non-cash fair value gain on investments.
Higher ICR sales volumes supported core operating performance, while Specialty Polymer and China GGBS faced weaker demand and pricing pressure.
Financial highlights
Revenue was $177.933m, up 70.3% YoY; other income increased to $4.132m from $2.169m.
Profit before tax rose to $36.674m from $8.804m; net profit was $35.194m versus $8.652m.
Net fair value gains on financial assets were $22.806m versus $6.086m; the 1H2026 gain was unrealised and non-cash.
Raw materials and consumables used rose to $107.043m from $65.826m; staff costs increased 40.2% YoY to $10.446m.
Operating cash flow was $10.3m; investing and financing cash outflows were $7.9m and $8.4m, respectively.
Outlook and guidance
Singapore construction demand is supported by the BCA’s 2026 forecast of $47bn–$53bn; Malaysia’s outlook benefits from data centres, infrastructure and JS-SEZ development.
ICR profit is expected to be lower in 2H2026, mainly due to anticipated higher logistics costs and demurrage charges amid possible weather-related shipment disruption.
Specialty Polymer demand is not expected to recover in 2H2026, with several Tier 1 and OEM projects deferred to 2027.
China GGBS conditions remain challenging as property-sector weakness, subdued cement demand, oversupply and pricing pressure are expected to persist.
Latest events from EnGro Corporation
- Revenue rose 6.5%, but profit after tax halved as China and investment income weakened.S44
H1 2023 - Revenue grew 20.6%, but China weakness and VC marks drove a S$5.6m net loss.S44
H2 2023 - Revenue grew 21.3%, but one-off and investment losses cut net profit to $20k.S44
H1 2024 - Construction-led revenue growth restored profitability despite China GGBS pressure and JV impairment.S44
H2 2024 - Revenue growth and fair-value gains lifted H1 profit; operating and market risks persist.S44
H1 2025 - Revenue rose 33.5%; investment gains lifted profit as supply-chain disruptions persisted.S44
H2 2025